Supply constraint of Creon® 2500 (Pancreatin) – 27th October 2023
Viatris, the marketing authorisation holder for Creon® in the UK, is currently experiencing a temporary supply constraint of Creon® 25000.
Due to compounding issues in the sourcing of active ingredient and the manufacturing process, Creon® 25000 is currently out of stock.
We have worked diligently with our supplier to expedite the next confirmed delivery date for the UK to w/c 6th November, which means that Creon® 25000 will next be available in retail pharmacies by w/c 13th November.
We continue to work with our suppliers to move this delivery date closer if possible and will keep healthcare professionals and pharmacists updated in due course.
Dosing of Creon® is based on lipase units. Creon® 10000 and Creon® Micro continue to be available as usual.
If you are a pharmacist and your preferred wholesaler is showing out of stock, please contact our Customer Service team via email: [email protected] or by phone on 01707 853 100, confirming the wholesaler(s) and depot name(s) and we may be able to advise further.
We are unable to make any specific treatment recommendations to healthcare professionals or for individual patients. It is recommended that patients speak to their treating healthcare professional to discuss treatment options according to their health needs and their relevant clinical history.
Charities have been updated with the current situation. Pancreatic Cancer UK runs a Support Line staffed by specialist nurses and they can support patients and their families, including information and support on PERT during this time. This Support Line can be reached on freephone 0808 801 0707, or by visiting www.pancreaticcancer.org.uk
Best Regards,
Chris Reed
Therapy Area Lead
Viatris